Duloxetine for the Treatment of Postpartum Depression


Major Depressive Disorder | Postpartum Depression

Trial Phase


Trial Purpose and Description

Trial Purpose

The purpose of this study is to assess whether the antidepressant, duloxetine, is equally effective as a treatment for subjects who have a Postpartum Onset Depression compared to subjects who have an onset of Major Depressive Disorder prior to delivery. The hypothesis is that duloxetine will be as effective in subjects with Postpartum Major Depressive Disorder as in subjects with a Major Depressive Disorder.

Participation Guidelines

18 Years and older

Eligibility Criteria

Inclusion Criteria:

- adult female subjects age 18 and above if onset of depression within 4 weeks of
delivery,or onset of depression antenatally either during pregnancy or before

- must score greater than or equal to 12 on the Edinburgh Postnatal Depression

- speak English or Spanish

- have access to a telephone

- provide written and verbal consent

Exclusion Criteria:

- have current or lifetime psychosis

- an unstable medical condition

- hypertension

- narrow-angle glaucoma

- liver disease

- seizure disorders

- bulimia

- anorexia

- mania

- substance abuse disorders

- have a known hypersensitivity to duloxetine or any of the active ingredients

- are in need of inpatient hospital treatment with an excluded medication

- adolescents under the age of 18

Medication Exclusion

- other antidepressants

- antipsychotic agents

- quinolone antibiotics

- Type 1C antiarrhythmics

- daily benzodiazepines

- Treatment with a monoamine oxidase inhibitor
Yale University
July 2007
Last Updated:
July 8, 2014
Study HIC#:

Clinicaltrials.gov ID: NCT00617045